These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 10565920

  • 1. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
    Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT.
    J Clin Microbiol; 1999 Dec; 37(12):3990-6. PubMed ID: 10565920
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.
    Liang FT, Jacobson RH, Straubinger RK, Grooters A, Philipp MT.
    J Clin Microbiol; 2000 Nov; 38(11):4160-6. PubMed ID: 11060084
    [Abstract] [Full Text] [Related]

  • 3. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP, Esty KJ, Hanscom JL, Shields P, Philipp MT.
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [Abstract] [Full Text] [Related]

  • 4. C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes.
    Liang FT, Bowers LC, Philipp MT.
    Infect Immun; 2001 May; 69(5):3224-31. PubMed ID: 11292744
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB, Collins MF, Young J, Schriefer ME.
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [Abstract] [Full Text] [Related]

  • 6. Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl.
    Liang FT, Nowling JM, Philipp MT.
    J Bacteriol; 2000 Jun; 182(12):3597-601. PubMed ID: 10852896
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.
    Marques AR, Martin DS, Philipp MT.
    J Clin Microbiol; 2002 Jul; 40(7):2591-3. PubMed ID: 12089281
    [Abstract] [Full Text] [Related]

  • 8. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi.
    Liang FT, Philipp MT.
    Infect Immun; 1999 Dec; 67(12):6702-6. PubMed ID: 10569796
    [Abstract] [Full Text] [Related]

  • 9. Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species.
    Liang FT, Philipp MT.
    Infect Immun; 2000 Apr; 68(4):2349-52. PubMed ID: 10722641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H, Lahdenne P, Sarvas H, Arnez M, Steere A, Peltomaa M, Seppälä I.
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [Abstract] [Full Text] [Related]

  • 12. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.
    Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP, Norris SJ.
    J Clin Microbiol; 1999 Dec; 37(12):3997-4004. PubMed ID: 10565921
    [Abstract] [Full Text] [Related]

  • 13. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.
    Liang FT, Aberer E, Cinco M, Gern L, Hu CM, Lobet YN, Ruscio M, Voet PE, Weynants VE, Philipp MT.
    J Infect Dis; 2000 Nov; 182(5):1455-62. PubMed ID: 11023468
    [Abstract] [Full Text] [Related]

  • 14. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans.
    Philipp MT, Bowers LC, Fawcett PT, Jacobs MB, Liang FT, Marques AR, Mitchell PD, Purcell JE, Ratterree MS, Straubinger RK.
    J Infect Dis; 2001 Oct 01; 184(7):870-8. PubMed ID: 11550127
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of serologic tests for lyme disease.
    Steere AC, McHugh G, Damle N, Sikand VK.
    Clin Infect Dis; 2008 Jul 15; 47(2):188-95. PubMed ID: 18532885
    [Abstract] [Full Text] [Related]

  • 16. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
    Peltomaa M, McHugh G, Steere AC.
    Otol Neurotol; 2004 Sep 15; 25(5):838-41. PubMed ID: 15354020
    [Abstract] [Full Text] [Related]

  • 17. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease.
    Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A.
    Clin Vaccine Immunol; 2010 Jun 15; 17(6):904-9. PubMed ID: 20392886
    [Abstract] [Full Text] [Related]

  • 18. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ, Wormser GP, Schriefer M, Neuman G, Hannafey L, Glass JD, Dattwyler RJ.
    J Clin Microbiol; 2002 Jan 15; 40(1):193-7. PubMed ID: 11773115
    [Abstract] [Full Text] [Related]

  • 19. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul 15; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 20. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT, Rose CD, Budd SM, Gibney KM.
    Clin Diagn Lab Immunol; 2001 Jan 15; 8(1):79-84. PubMed ID: 11139199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.